Financhill
Sell
49

NVCR Quote, Financials, Valuation and Earnings

Last price:
$30.16
Seasonality move :
-8.57%
Day range:
$29.85 - $31.03
52-week range:
$11.70 - $34.13
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
5.67x
P/B ratio:
9.14x
Volume:
700.6K
Avg. volume:
1.6M
1-year change:
129.25%
Market cap:
$3.3B
Revenue:
$509.3M
EPS (TTM):
-$1.40

Earnings Data

Next earnings date for NVCR
Feb 21
2025
Most recent earnings per share
-$0.28
Beat by $0.05
(Oct 30/2024)
Consensus Estimate
-$0.33
(Oct 30/2024)

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

NVCR Quarterly Earnings History

Date Quarter Revenue Forecast Actual Revenue Reported EPS Consensus EPS Beat/Miss
02/21/2025 Q4 $153M -- -- -$0.36 --
10/30/2024 Q3 $143.9M $155.1M -$0.28 -$0.33 $0.05
07/25/2024 Q2 $135.8M $150.4M -$0.31 -$0.40 $0.09
05/02/2024 Q1 $131.4M $138.5M -$0.36 -$0.42 $0.06
02/22/2024 Q4 $133.8M $133.8M -$0.45 -$0.52 $0.07
10/26/2023 Q3 -- -- -$0.46 -$0.53 $0.07
07/27/2023 Q2 -- -- -$0.54 -$0.50 -$0.04
05/04/2023 Q1 -- -- -$0.50 -$0.34 -$0.16
02/23/2023 Q4 -- -- -$0.36 -$0.31 -$0.05
10/27/2022 Q3 -- -- -$0.25 -$0.26 $0.01
07/28/2022 Q2 -- -- -$0.23 -$0.14 -$0.09
04/28/2022 Q1 -- -- -$0.04 -$0.19 $0.15
02/24/2022 Q4 -- -- -$0.25 -$0.10 -$0.15
10/28/2021 Q3 -- -- -$0.13 -$0.06 -$0.07
07/29/2021 Q2 -- -- -$0.14 $0.01 -$0.15
04/29/2021 Q1 -- -- -$0.04 $0.01 -$0.05
02/25/2021 Q4 -- -- $0.04 $0.13 -$0.09
10/29/2020 Q3 -- -- $0.09 $0.04 $0.05
07/30/2020 Q2 -- -- $0.02 $0.01 $0.01
04/30/2020 Q1 -- -- $0.04 $0.03 $0.01
02/27/2020 Q4 -- -- $0.04 $0.00 $0.04
10/31/2019 Q3 -- -- $0.02 -$0.04 $0.06
07/25/2019 Q2 -- -- -$0.01 -$0.06 $0.05
05/02/2019 Q1 -- -- -$0.13 -$0.15 $0.02
02/28/2019 Q4 -- -- -$0.17 -$0.13 -$0.04
10/25/2018 Q3 -- -- -$0.13 -$0.14 $0.01
07/26/2018 Q2 -- -- -$0.17 -$0.16 -$0.01
04/26/2018 Q1 -- -- -$0.23 -$0.13 -$0.10
02/22/2018 Q4 -- -- -$0.12 -$0.12 $0.00
10/26/2017 Q3 -- -- -$0.13 -$0.14 $0.01
07/27/2017 Q2 -- -- -$0.24 -$0.22 -$0.02
04/27/2017 Q1 -- -- -$0.21 -$0.20 -$0.01

NovoCure Earnings Questions

  • How Much did NovoCure Generate in Revenue Last Quarter?

    NovoCure reported $155.1M worth of top line sales in its most recent quarter.

  • Did NovoCure Beat Earnings Last Quarter?

    NovoCure announced earnings per share of -$0.28 which represents a beat of analyst forecast a -$0.33 per share.

  • Is NovoCure Profitable?

    NovoCure reported $119.7M that represents $1.11 per share over the last quarter.

  • What is the Analyst Consensus for NovoCure EPS Next Year?

    NovoCure's earnings are forecast to decrease from -$1.95 per share to -$2.02 per share next year representing a decrease of -32.57%.

  • When is NovoCure's Earnings Date?

    NovoCure's next earnings date is February 21, 2025.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Tesla Going to Buy Uber?
Is Tesla Going to Buy Uber?

Tesla has always been in the habit of making large,…

NVIDIA vs Broadcom Stock: Which Is Best?
NVIDIA vs Broadcom Stock: Which Is Best?

If you want to invest in an AI-leading tech company,…

Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret
Why Caesars’ Digital Arm May Be the Gaming Giant’s Best-Kept Secret

It’s not often that a company with the scale and…

Stock Ideas

Buy
65
Is AAPL Stock a Buy?

Market Cap: $3.9T
P/E Ratio: 42x

Buy
57
Is NVDA Stock a Buy?

Market Cap: $3.4T
P/E Ratio: 117x

Buy
53
Is MSFT Stock a Buy?

Market Cap: $3.2T
P/E Ratio: 37x

Alerts

Sell
40
MSTR alert for Dec 24

MicroStrategy [MSTR] is up 8.12% over the past day.

Sell
26
NUTX alert for Dec 24

Nutex Health [NUTX] is down 0.76% over the past day.

Sell
48
VRNA alert for Dec 24

Verona Pharma PLC [VRNA] is down 0.73% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock